Company

Immuneel Therapeutics

Cell and gene therapy developerimmuneel.com ↗LinkedIn ↗

Healthcare & Life SciencesBengaluruFounded 2018

Immuneel Therapeutics key numbers

₹100 CrTotal raised · 2026Source: Immuneel raises ₹100 Cr in Series B

As reported on the date of each story; tap a number for its source.

Stories cover its funding news. Sectors: Healthcare & Life Sciences. Stages: Series-b. Based in Bengaluru.

The founders

Kiran Mazumdar-Shaw

co-founder, existing investor

Co-founder of Immuneel Therapeutics.
Also an existing investor in the company.

Kush M Parmar

co-founder

Co-founder of Immuneel Therapeutics.

Siddhartha Mukherjee

co-founder

Co-founder of Immuneel Therapeutics.

Who put in money

Eight Roads VenturesF-Prime CapitalKiran Mazumdar-ShawRainmatter by Zerodha Singularity AMC

Up against

CellogenOncare

Every story on Immuneel Therapeutics

ITImmuneel Therapeutics · Funding · 8 June 2026 · ₹100 CrImmuneel raises ₹100 Cr in Series BImmuneel Therapeutics develops cell and gene therapies for cancer

For Immuneel Therapeutics: add the “Featured on StopDown” badge

Put this on your website's press or media page. It links readers to Immuneel Therapeutics on StopDown.

Light

<a href="https://stopdown.in/company/immuneeltherapeutics" target="_blank" title="Immuneel Therapeutics on StopDown"><img src="https://stopdown.in/badge/featured-light@2x.png" alt="Featured on StopDown" width="232" height="56" style="border:0"></a>

Dark

<a href="https://stopdown.in/company/immuneeltherapeutics" target="_blank" title="Immuneel Therapeutics on StopDown"><img src="https://stopdown.in/badge/featured-dark@2x.png" alt="Featured on StopDown" width="232" height="56" style="border:0"></a>

· About the badge

#Immuneel Therapeutics key numbers

●The founders